Proof-of-principle experiments have described the use of oligonucleotide microarrays to profile transcript isoforms generated by alternative expression, but resources to create such arrays are lacking ...
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...
A strategic partnership between Vaxxas and Profenso, an Australian AI company specialising in advanced automation for regulated industries, has been announced.
Multiplexing Breakthroughs, Automation, and Bioinformatics Convergence Position Protein Microarrays as a Strategic Imperative for Precision Medicine LeadersDelray Beach, FL, Feb. 24, 2026 (GLOBE ...
Non-invasive prenatal testing (NIPT) is a simple blood test during pregnancy that helps detect rare genetic conditions early, ...
Methods developed and validated to establish the “World Bank of NK Cells” from healthy donors and cancer patientsSingle ...
U.S. Gene Expression Analysis Market size is USD 1.28 Billion in 2025 and is expected to reach USD 2.45 Billion by 2035 owing to high penetration of advanced molecular analysis technologies.Austin, ...
Drug resistance in cancer is a major obstacle to successful chemotherapy. Cancer cells exposed to antitumour drugs may be directly induced to express a subset of genes that could confer resistance, ...
Microliter dispensing pumps deliver accurate low-volume dosing to support laboratory, diagnostic, and industrial fluid ...
Infectious keratitis remains a leading cause of corneal blindness and visual impairment worldwide, with bacterial, fungal, ...
Molecular profiling of tumors has been shown to improve risk stratification, and it may be useful for prostate cancer active surveillance.
The statistical interaction between genetic susceptibility and lifestyle was significant in the larger cohort and showed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results